Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere
Drug giant Merck & Co. Inc. will cut research jobs at three East Coast sites as it searches for a major Bay Area home to consolidate its cancer and biologics R&D work and hire about 100 scientists.
The company (NYSE: MRK) will move into an interim facility in South San Francisco early next year, according to a spokeswoman for the Kenilworth. N.J.-based maker of the Gardasil human papillomavirus vaccine, cancer immunotherapy drug Keytruda and a host of other products. But it is continuing a search…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Eyes | Gardasil | Genital Warts | Health | Health Management | Human Papillomavirus (HPV) | Immunotherapy | Jobs | Merck | Pharmaceuticals | Vaccines